MAALOX SACHETS

460/400 Milligram Oral Suspension

Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/110/006

SPC: Overdose

Serious symptoms are unlikely following overdosage.

« Back

Latest Changes to Medicine Info & SPC


Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.